Porcine brain peptide hydrolysate, EU Rx, stroke + dementia.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

WHAT IS CEREBROLYSIN?
Cerebrolysin (EVER Pharma, Austria) is a biological medicine hydrolyzed from porcine brain cortex into peptide and free amino acid fractions (the FPF1070 enzymatic process). 25% peptides (<10 kDa), 75% free amino acids. Clinical evidence: **CASTA trial (Heiss 2012, PMID 22744651)** – acute ischemic stroke, intent-to-treat NIH SS improvement; **CARS-1 trial (Muresanu 2016, PMID 26669311)** – stroke rehabilitation, statistically significant functional recovery. Mechanism: NGF, BDNF, GDNF, CNTF-like peptide activity → neurogenesis in the subventricular zone, anti-excitotoxic + anti-apoptotic effects. Administration: 10-30 ml i.v. infusion over 10-20 days (acute stroke), repeatable every 4-6 weeks. Prescription-only in Hungary and several EU member states (AT, PL, RU, CN). Not FDA-approved in the USA (cannot be classified under standard biological-drug categories).
Mechanism
Neurotrophic + neuroprotective peptides
Route
i.v. / i.m. injection
Legal status
EU Rx (HU, AT)
Safety
Side effects · 6
Contraindications · 6
Related Nootropics
Telegram
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.